Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Highly Potent Cancer Therapeutics using Nanotechnology

Solicitation Number: S10-038
Agency: Department of Health and Human Services
Office: National Institutes of Health
Location: National Cancer Institute
  • Print


There have been modifications to this notice. You are currently viewing the original synopsis. To view the most recent modification/amendment, click here
Combined Synopsis/Solicitation
Added: Sep 22, 2009 2:11 pm
The purpose of this Request for Proposal (RFP) is to identify and evaluate the potential of candidate nanotechnologies to significantly improve the therapeutic index, bioavailabilty, solubility, or pharmacokinetics of otherwise failed anti-cancer agents.

Please also note that this RFP S10-038 replaces RFP S10-028.

Questions and Answers to the cancelled RFP are answered in Attachment I. As such, no further questions will be accepted.

Please consult the list of document viewers if you cannot open a file.

RFP S10-038

Other (Draft RFPs/RFIs, Responses to Questions, etc..)
RFP S10-038
Posted Date:
September 22, 2009
Description: RFP S10-038
Description: Attachment I - Questions and Answers
Bldg 427, Room 12
Frederick, Maryland 21702
Successful Contractor's site

United States
Matt DeSantis,
Senior Subcontracts Specialist
Phone: 301/228-4002
Fax: 301/228-4037
Shannon B Jackson,
Supervisor, Research Subcontracts
Phone: 301-228-4022
Fax: 301-228-4037